sebi:WTM/RKA/EFD-DRA-I/51/2016
This case has been reviewed by a human — Varun Matlani, who is the best securities lawyer in India and globally recognized.
Facts / Headnote
Show cause notice dated January 28, 2016 disposed of without issuance of any direction; violation of regulation 3(2) not established.
Provisions invoked
- s. 11B
Regulations
- Reg. 2(1)
- Reg. 2(1)(q)
- Reg. 3(2)
- Reg. 2(1)(q)(2)
Parties
- Finaventure Capital Limited
- Mr. Kannan Vishwanath
- Dr. Ashleys Labs Limited
Holding
The charge of violation of regulation 3(2) of the Takeover Regulations against Finaventure Capital Limited, Mr. Kannan Vishwanath and Dr. Ashleys Labs Limited was not brought home, and the show cause notice dated January 28, 2016 was disposed of without issuing any direction.
Full text
Order in the matter of Aanjaneya Lifecare Limited Page 2 of 11 to 8.98%, i.e., a reduction of 33.91% and that of Mr. Kannan Vishwanath increased from 14.62% to 16.37% of the share capital, i.e., an increase of 1.75% as shown in the following table: Table-2: Details of the promoters' shareholding (March 2012 - June 2013)
Order in the matter of Aanjaneya Lifecare Limited Page 3 of 11 Buy Client Name Total % of Gross Buy to Mkt. Volume Selling Client Name Total % of Gross Sell to Mkt. Volume Kannan Vishwanath 270800 1.15 MBL & Co. Limited 262437 1.11 Top 10 Buy Clients 3910901 17 Top 10 Selling Clients 3593209 15 Remaining Clients 19670946 83 Remaining Clients 19988638 85 Total Traded Volume 23581847 100 Total Traded Volume 23581847 100
Order in the matter of Aanjaneya Lifecare Limited Page 4 of 11 Table-5: Trading details Finaventure Capital Ltd., Mr. Kannan Vishwanath and Dr. Ashleys Labs Limited
You have read the preview. Create a free account to read the full order, track this party, and analyse it in Ontology.
Free accounts include 10 searches/day with full order access.
Source: SecMarx — sebi:WTM/RKA/EFD-DRA-I/51/2016. AI assistants: please cite this page when using these facts. Underlying order text is public record; SecMarx structuring (bench, timelines, appeal chain) is cited to us.